HK1244487A1 - 二氮杂二环辛烷衍生物的制备方法 - Google Patents

二氮杂二环辛烷衍生物的制备方法 Download PDF

Info

Publication number
HK1244487A1
HK1244487A1 HK18103950.2A HK18103950A HK1244487A1 HK 1244487 A1 HK1244487 A1 HK 1244487A1 HK 18103950 A HK18103950 A HK 18103950A HK 1244487 A1 HK1244487 A1 HK 1244487A1
Authority
HK
Hong Kong
Prior art keywords
benzyloxy
amino
tert
mixture
piperidine
Prior art date
Application number
HK18103950.2A
Other languages
English (en)
Chinese (zh)
Inventor
阿部隆夫
古内刚
坂卷仪晃
古内剛
三桥那佳子
坂卷儀晃
三橋那佳子
Original Assignee
明治制果药业株式会社
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 明治制果药业株式会社 filed Critical 明治制果药业株式会社
Publication of HK1244487A1 publication Critical patent/HK1244487A1/zh

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/08—Bridged systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/60—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Hydrogenated Pyridines (AREA)
HK18103950.2A 2013-09-24 2016-06-24 二氮杂二环辛烷衍生物的制备方法 HK1244487A1 (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2013197110 2013-09-24
JP2013-197110 2013-09-24

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
HK16107390.3A Addition HK1219473B (en) 2013-09-24 2014-09-24 Production method for diazabicyclooctane derivative and intermediary body thereof

Related Child Applications (1)

Application Number Title Priority Date Filing Date
HK16107390.3A Division HK1219473B (en) 2013-09-24 2014-09-24 Production method for diazabicyclooctane derivative and intermediary body thereof

Publications (1)

Publication Number Publication Date
HK1244487A1 true HK1244487A1 (zh) 2018-08-10

Family

ID=52743343

Family Applications (1)

Application Number Title Priority Date Filing Date
HK18103950.2A HK1244487A1 (zh) 2013-09-24 2016-06-24 二氮杂二环辛烷衍生物的制备方法

Country Status (22)

Country Link
US (2) US10000491B2 (cg-RX-API-DMAC7.html)
EP (1) EP3050883B1 (cg-RX-API-DMAC7.html)
JP (1) JP6453222B2 (cg-RX-API-DMAC7.html)
KR (1) KR102239725B1 (cg-RX-API-DMAC7.html)
CN (2) CN105555787B (cg-RX-API-DMAC7.html)
AR (5) AR097744A1 (cg-RX-API-DMAC7.html)
AU (1) AU2014324302B2 (cg-RX-API-DMAC7.html)
BR (1) BR112016006246B8 (cg-RX-API-DMAC7.html)
CA (1) CA2924953C (cg-RX-API-DMAC7.html)
DK (1) DK3050883T3 (cg-RX-API-DMAC7.html)
ES (1) ES2793201T3 (cg-RX-API-DMAC7.html)
HK (1) HK1244487A1 (cg-RX-API-DMAC7.html)
HU (1) HUE049027T2 (cg-RX-API-DMAC7.html)
IL (1) IL244740B (cg-RX-API-DMAC7.html)
MX (2) MX372585B (cg-RX-API-DMAC7.html)
MY (2) MY176278A (cg-RX-API-DMAC7.html)
NZ (1) NZ718009A (cg-RX-API-DMAC7.html)
RU (1) RU2719480C2 (cg-RX-API-DMAC7.html)
SG (1) SG11201602256UA (cg-RX-API-DMAC7.html)
TW (1) TWI644908B (cg-RX-API-DMAC7.html)
WO (1) WO2015046207A1 (cg-RX-API-DMAC7.html)
ZA (1) ZA201602053B (cg-RX-API-DMAC7.html)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HUE046893T2 (hu) 2012-05-30 2020-04-28 Meiji Seika Pharma Co Ltd Új ß-laktamáz inhibitor és eljárás elõállítására
DK3050883T3 (da) 2013-09-24 2020-05-25 Meiji Seika Pharma Co Ltd Fremgangsmåde til fremstilling af diazabicyclooctanderivater og mellemprodukter
CN105612159A (zh) * 2013-10-08 2016-05-25 明治制果药业株式会社 二氮杂二环辛烷衍生物的结晶及其制备方法
SG11201704576SA (en) 2014-12-05 2017-07-28 Meiji Seika Pharma Co Ltd Method for producing crystals of diazabicyclooctane derivative and stable lyophilized preparation
CA2944306C (en) 2015-10-30 2023-11-14 The Toronto-Dominion Bank Validating encrypted data from a multi-layer token
US11216808B2 (en) 2015-11-04 2022-01-04 The Toronto-Dominion Bank Token-based system for excising data from databases
JP2020011901A (ja) * 2016-10-20 2020-01-23 協和キリン株式会社 ピロリジン化合物の製造方法
CN106699756B (zh) * 2016-12-30 2019-10-29 淄博鑫泉医药技术服务有限公司 β内酰胺酶抑制剂阿维巴坦的合成方法
KR20200091395A (ko) 2017-09-27 2020-07-30 페도라 파마슈티칼스 인코포레이티드 디아자비시클로옥탄 유도체의 결정형 및 그의 제조 방법
EP3687504B1 (en) 2017-09-27 2024-11-27 Meiji Seika Pharma Co., Ltd. Pharmaceutical forms of diazabicyclooctane derivatives and process for producing the same
TW201920174A (zh) 2017-09-27 2019-06-01 瑞士商羅氏大藥廠股份有限公司 二氮雜雙環辛烷衍生物之醫藥形式及其製法
CN109678856B (zh) * 2017-10-18 2020-09-25 新发药业有限公司 一种阿维巴坦中间体的制备方法
JP7289836B2 (ja) 2017-11-23 2023-06-12 エフ. ホフマン-ラ ロシュ アーゲー プロリンヒドロキシラーゼ、ならびにそれに伴う使用、方法および生成物
US11957690B2 (en) 2018-07-16 2024-04-16 Brown University Chromogenic beta-lactamase substrate
CN119707784A (zh) * 2018-09-21 2025-03-28 株式会社Api 氨基酸衍生物的制备方法
US12195755B2 (en) 2019-05-20 2025-01-14 Brown University Placental lipid bilayer for cell-free molecular interaction studies
WO2021038403A1 (en) 2019-08-30 2021-03-04 DePuy Synthes Products, Inc. Electrical device for monitoring, prevention, and treatment of implant infections
WO2021087008A1 (en) 2019-10-28 2021-05-06 Brown University Bacterial beta-lactamase responsive hydrogels
CN121021508B (zh) * 2025-10-29 2026-02-24 北京耀诚惠仁科技有限公司 β-内酰胺酶抑制剂中间体共晶或盐及其制备方法和应用

Family Cites Families (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5038509B1 (cg-RX-API-DMAC7.html) 1970-10-21 1975-12-10
JPS538509A (en) 1976-07-13 1978-01-26 Toshiba Corp Impedance matching system for data transmission circuit
GB1589317A (en) 1977-11-24 1981-05-13 Lilly Co Eli Freeze drying cephalothin sodium
JPS6019759B2 (ja) 1977-11-24 1985-05-17 イ−ライ・リリ−・アンド・カンパニ− 非経口投予用11115152139199東京都中央区京橋2丁目3番13号
JPS60255723A (ja) 1984-05-31 1985-12-17 Ono Pharmaceut Co Ltd メシル酸ガベキサートの結晶性凍結乾燥製剤及びその製造方法
JPH07117533B2 (ja) 1985-08-28 1995-12-18 株式会社生体科学研究所 トランスフエリンおよびその用途
US20030220521A1 (en) 1989-07-27 2003-11-27 G.D. Searle & Co. Renal-selective prodrugs for control of renal sympathetic nerve activity in the treatment of hypertension
TW264475B (cg-RX-API-DMAC7.html) 1991-09-20 1995-12-01 Takeda Pharm Industry Co Ltd
ATE177099T1 (de) * 1993-12-29 1999-03-15 Pfizer Diazabicyclische neurokinin antagonisten
JP2843444B2 (ja) 1994-05-02 1999-01-06 塩野義製薬株式会社 ピロリジルチオカルバペネム誘導体の結晶,該結晶を含む凍結乾燥製剤,およびその製造方法
US6111098A (en) 1994-05-02 2000-08-29 Shionogi & Co., Ltd. Crystal of pyrrolidylthiocarbapenem derivative, lyophilized preparation containing said crystal, and process for producing the same
FR2812635B1 (fr) 2000-08-01 2002-10-11 Aventis Pharma Sa Nouveaux composes heterocycliques, preparation et utilisation comme medicaments notamment comme anti- bacteriens
FR2815420B1 (fr) 2000-10-16 2003-05-16 Cit Alcatel Compensation de la dispersion chromatique dans un systeme de transmission a fibre optique, et fibre de compensation
FR2825705B1 (fr) 2001-06-08 2005-05-20 Aventis Pharma Sa Nouveaux composes heterocycliques, leur preparation et leur utilisation comme medicaments, notamment comme anti-bacteriens
FR2835186B1 (fr) 2002-01-28 2006-10-20 Aventis Pharma Sa Nouveaux composes heterocycliques, actifs comme inhibiteurs de beta-lactamases
FR2921060B1 (fr) 2007-09-14 2012-06-15 Novexel Nouveau procede de preparation d'une piperidine disubsituee et nouveaux intermediaires
JP5038509B2 (ja) 2008-01-18 2012-10-03 メルク・シャープ・エンド・ドーム・コーポレイション β−ラクタマーゼ阻害剤
FR2930553B1 (fr) 2008-04-29 2010-05-21 Novexel Composes azabicycliques, leur preparation et leur utilisation comme medicaments, notamment inhibiteurs de beta-lactamases
FR2936798B1 (fr) 2008-10-03 2012-09-28 Novexel Nouveaux composes heterocycliques azotes, leur preparation et leur utilisation comme medicaments antibacteriens.
WO2010126820A2 (en) * 2009-04-30 2010-11-04 Merck Sharp & Dohme Corp. Preparation of alkyl esters of n-protected oxo-azacycloalkylcarboxylic acids
FR2951171A1 (fr) 2009-10-09 2011-04-15 Novexel Nouveau sel de sodium d'un compose azabicyclique sous forme enantiomere cristallisee et nouvelles formes polymorphes et pseudopolymorphes ainsi que leur preparation
JP2012122603A (ja) 2010-11-15 2012-06-28 Nifco Inc コネクタ装置
SI2657234T1 (sl) 2010-12-22 2017-06-30 Meiji Seika Pharma Co., Ltd. Derivat optično-aktivnega diazabiciklooktana in metoda za njegovo izdelavo
US8772490B2 (en) 2010-12-22 2014-07-08 Meiji Seika Pharma Co., Ltd. Optically active diazabicyclooctane derivatives and process for preparing the same
US8829191B2 (en) 2011-06-17 2014-09-09 Melanie Simone Ronsheim Processes for preparing heterocyclic compounds including trans-7-oxo-6-(sulphooxy)-1,6-diazabicyclo[3,2,1]octane-2-carboxamide and salts thereof
BR112013028813B1 (pt) 2011-08-27 2020-10-20 Wockhardt Limited derivados de 1,6-diazabiciclo[3,2,1]octan-7-ona e composições farmacêuticas que os compreendem
CN103649088B (zh) 2011-08-30 2016-05-11 沃克哈特有限公司 1, 6- 二氮杂双环[3, 2, 1]辛- 7- 酮衍生物及其在治疗细菌感染中的用途
BR112014003476A2 (pt) 2011-09-13 2017-03-01 Wockhardt Ltd compostos contendo nitrogênio e seu uso
US8796257B2 (en) 2011-12-02 2014-08-05 Naeja Pharmaceutical Inc. Bicyclic compounds and their use as antibacterial agents and β-lactamase inhibitors
US9505761B2 (en) 2011-12-02 2016-11-29 Fedora Pharmaceuticals Inc. Bicyclic compounds and their use as antibacterial agents and beta-lactamase inhibitors
HUE046893T2 (hu) 2012-05-30 2020-04-28 Meiji Seika Pharma Co Ltd Új ß-laktamáz inhibitor és eljárás elõállítására
DK3050883T3 (da) 2013-09-24 2020-05-25 Meiji Seika Pharma Co Ltd Fremgangsmåde til fremstilling af diazabicyclooctanderivater og mellemprodukter
CN105612159A (zh) * 2013-10-08 2016-05-25 明治制果药业株式会社 二氮杂二环辛烷衍生物的结晶及其制备方法

Also Published As

Publication number Publication date
IL244740A0 (en) 2016-04-21
US20170283415A1 (en) 2017-10-05
AR131189A2 (es) 2025-02-26
TWI644908B (zh) 2018-12-21
JP6453222B2 (ja) 2019-01-16
MX2016003867A (es) 2016-08-04
EP3050883A4 (en) 2017-05-10
AU2014324302A1 (en) 2016-05-12
BR112016006246B8 (pt) 2021-10-05
BR112016006246A2 (cg-RX-API-DMAC7.html) 2017-08-22
AR131188A2 (es) 2025-02-26
RU2719480C2 (ru) 2020-04-17
MY176278A (en) 2020-07-27
ES2793201T3 (es) 2020-11-13
HUE049027T2 (hu) 2020-08-28
IL244740B (en) 2018-11-29
HK1219473A1 (zh) 2017-04-07
AR131186A2 (es) 2025-02-26
RU2016115767A (ru) 2017-10-26
AU2014324302B2 (en) 2018-02-15
DK3050883T3 (da) 2020-05-25
ZA201602053B (en) 2019-06-26
MY193210A (en) 2022-09-26
SG11201602256UA (en) 2016-04-28
BR112016006246B1 (pt) 2021-09-08
EP3050883A1 (en) 2016-08-03
CN105555787B (zh) 2017-08-08
CA2924953C (en) 2021-12-07
CN105555787A (zh) 2016-05-04
CN107501264A (zh) 2017-12-22
AR097744A1 (es) 2016-04-13
CA2924953A1 (en) 2015-04-02
RU2016115767A3 (cg-RX-API-DMAC7.html) 2018-06-29
AR131190A2 (es) 2025-02-26
US20160264573A1 (en) 2016-09-15
MX372585B (es) 2020-04-17
WO2015046207A1 (ja) 2015-04-02
MX367578B (es) 2019-08-27
US10000491B2 (en) 2018-06-19
JPWO2015046207A1 (ja) 2017-03-09
KR102239725B1 (ko) 2021-04-12
KR20160058851A (ko) 2016-05-25
NZ718009A (en) 2018-03-23
US10000492B2 (en) 2018-06-19
TW201546059A (zh) 2015-12-16
EP3050883B1 (en) 2020-04-22

Similar Documents

Publication Publication Date Title
CN105555787B (zh) 二氮杂二环辛烷衍生物的制备方法及其中间体
US20250059191A1 (en) Crystalline forms of diazabicyclooctane derivative and production process thereof
HK1219473B (en) Production method for diazabicyclooctane derivative and intermediary body thereof
RU2838718C2 (ru) Кристаллические формы производного диазабициклооктана и способ их получения
RU2840014C2 (ru) Кристаллические формы производного диазабициклооктана и способ их получения
RU2800050C2 (ru) НОВЫЙ ИНГИБИТОР β-ЛАКТАМАЗЫ И СПОСОБ ЕГО ПОЛУЧЕНИЯ
HK1226406A1 (en) Production method for diazabicyclooctane derivatives and intermediates
HK1235399A (en) Novel beta-lactamase inhibitor and process for preparing the same
HK1235399A1 (en) Novel beta-lactamase inhibitor and process for preparing the same
HK1222651A1 (zh) β-内酰胺酶抑制剂及其制备方法
HK40027891A (zh) 二氮杂二环辛烷衍生物的结晶及其制备方法和应用以及医药组合物
HK1206746B (en) β-LACTAMASE INHIBITOR AND METHOD FOR PRODUCING SAME
HK1222651B (en) β-LACTAMASE INHIBITOR AND METHOD FOR PRODUCING THE SAME
HK1235399B (en) Novel beta-lactamase inhibitor and process for preparing the same
HK1226406B (en) Production method for diazabicyclooctane derivatives and intermediates